Organization
Emmaus Medical, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Emmaus Medical, Inc.
... patient education initiatives to address the complications of sickle cell disease (SCD). Emmaus will provide unrestricted funding to provide educational materials for individuals living with ...
... that US Bioservices, an independent specialty pharmacy, has been selected by Emmaus Medical, Inc. as the specialty pharmacy for EndariTM (L-glutamine oral powder), for the ...
... Annual Meeting of the American Society of Hematology (ASH) in Atlanta, Georgia, Emmaus announced availability of Endari (L-glutamine oral powder) for sickle cell disease treatment. ...
... FDA greenlight for sickle cell disease therapy Endari has catapulted its developer, Emmaus Medical, into the spotlight, but commercializing the new drug could be challenging. ...
... from vendors to develop a product for a rare disease. Key vendors Emmaus MedicalMerckShire Other prominent vendors ArdelyxNaia PharmaceuticalsNutriniaOxTheraSancilio PharmaceuticalsZealand Pharma Key Topics Covered: PART ...
... as the key players in the global short bowel syndrome (SBS) market: Emmaus Medical, Merck, and Shire. Other Prominent Vendors in the market are: Ardelyx, ...
... �Emmaus Medical, a subsidiary of Emmaus Life Sciences, Inc., a biopharmaceutical company engaged ...
... Pharmaceuticals, Inc., Acino Pharma AG, Alnylam Pharmaceuticals, Inc., Bluebird bio, Inc., Emmaus Medical, Inc., Errant Gene Therapeutics, LLC, Gamida Cell Ltd., Incyte Corporation, IRBM Science ...
... Its Phase 3 Clinical Trial For Treatment Of Sickle Cell Disease . Emmaus Medical Announces Completion Of All Patient Visits For Its Phase 3 Clinical ...
... Emmaus Medical as Regulatory Advisor . Former FDA Official Tim Cote Joins Emmaus Medical as Regulatory Advisor Timothy Cote, M.D., MPH, former director of the ...
Subscribe now for full coverage on Emmaus Medical, Inc.
Start My Free Trial